Procalcitonin levels in patients with positive blood culture, positive body fluid culture, sepsis, and severe sepsis: A cross-sectional study

Infectious Diseases

Volumn 48, Issue 1, 2016, Pages 63-69

  Yu, Ying ^a   Li, Xia Xi ^a   Jiang, Ling Xiao ^b   Du, Meng ^a   Liu, Zhan Guo ^a   Cen, Zhongran ^a   Wang, Hua ^a   Guo, Zhen Hui ^c   Chang, Ping ^a  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

^b SOUTHERN MEDICAL UNIVERSITY   (China)

^c GUANGZHOU GENERAL HOSPITAL OF GUANGZHOU MILITARY COMMAND   (China)

Author keywords

Procalcitonin, blood culture, body fluid culture, sepsis, severe sepsis

Indexed keywords

PROCALCITONIN; BIOLOGICAL MARKER; C REACTIVE PROTEIN; CALCITONIN; PROTEIN PRECURSOR;

ADOLESCENT; ADULT; AGED; ARTICLE; ASCITES; BLOOD CULTURE; BODY FLUID; BODY FLUID CULTURE; CEREBROSPINAL FLUID CULTURE; CROSS-SECTIONAL STUDY; FEMALE; HOSPITAL PATIENT; HUMAN; HYDROTHORAX; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; PROTEIN BLOOD LEVEL; RETROSPECTIVE STUDY; SEPSIS; ALGORITHM; BACTEREMIA; BLOOD; CHILD; CHINA; HOSPITALIZATION; MICROBIOLOGY; MIDDLE AGED; SEVERITY OF ILLNESS INDEX; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; ALGORITHMS; BACTEREMIA; BIOMARKERS; BODY FLUIDS; C-REACTIVE PROTEIN; CALCITONIN; CHILD; CHINA; CROSS-SECTIONAL STUDIES; FEMALE; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; PROTEIN PRECURSORS; RETROSPECTIVE STUDIES; SEPSIS; SEVERITY OF ILLNESS INDEX; YOUNG ADULT;

EID: 84962243954     PISSN: 23744235     EISSN: None     Source Type: Journal    
DOI: 10.3109/23744235.2015.1082618     Document Type: Article

References (40)

1. Levy MM, Artigas A, Phillips GS, Rhodes A, Beale R, Osborn T, et al. Outcomes of the Surviving Sepsis Campaign in intensive care units in the USA and Europe: a prospective cohort study. Lancet Infect Dis 2012; 12: 919-24.
2. Enguix A, Rey C, Concha A, Medina A, Coto D, Dieguez MA. Comparison of procalcitonin with C-reactive protein and serum amyloid for the early diagnosis of bacterial sepsis in critically ill neonates and children. Intensive Care Med 2001; 27: 211-15.
3. Levy MM, Fink MP, Marshall JC, Abraham E, Angus D, Cook D, et al. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med 2003; 31: 1250-6.
4. Munson EL, Diekema DJ, Beekmann SE, Chapin KC, Doern GV. Detection and treatment of bloodstream infection: laboratory reporting and antimicrobial management. J Clin Microbiol 2003; 41: 495-7.
5. Khatib R, Saeed S, Sharma M, Riederer K, Fakih MG, Johnson LB. Impact of initial antibiotic choice and delayed appropriate treatment on the outcome of Staphylococcus aureus bacteremia. Eur J Clin Microbiol Infect Dis 2006; 25: 181-5.
6. Kumar A, Roberts D, Wood KE, Light B, Parrillo JE, Sharma S, et al. Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med 2006; 34: 1589-96.
7. Clerico A, Plebani M. Biomarkers for sepsis: an unfinished journey. Clin Chem Lab Med 2013; 51: 1135-8.
8. Di Somma S, Magrini L, Travaglino F, Lalle I, Fiotti N, Cervellin G, et al. Opinion paper on innovative approach of biomarkers for infectious diseases and sepsis management in the emergency department. Clin Chem Lab Med 2013; 51: 1167-75.
9. Tromp M, Lansdorp B, Bleeker-Rovers CP, Gunnewiek JM, Kullberg BJ, Pickkers P. Serial and panel analyses of biomarkers do not improve the prediction of bacteremia compared to one procalcitonin measurement. J Infect 2012; 65: 292-301.
10. Vincent JL, Sakr Y, Sprung CL, Ranieri VM, Reinhart K, Gerlach H, et al. Sepsis in European intensive care units: results of the SOAP study. Crit Care Med 2006; 34: 344-53.
11. Jacobs JW, Lund PK, Potts JJ, Bell NH, Habener JF. Procal-citonin is a glycoprotein. J Biol Chem 1981; 256: 2803-7.
12. Reinhart K, Karzai W, Meisner M. Procalcitonin as a marker of the systemic infl ammatory response to infection. Intensive Care Med 2000; 26: 1193-200.
13. Muller B, Christ-Crain M, Nylen ES, Snider R, Becker KL. Limits to the use of the procalcitonin level as a diagnostic marker. Clin Infect Dis 2004; 39: 1867-8.
14. Christ-Crain M, Muller B. Procalcitonin in bacterial infections-hype, hope, more or less? Swiss Med Wkly 2005; 135: 451-60.
15. Christ-Crain M, Muller B. Biomarkers in respiratory tract infections: diagnostic guides to antibiotic prescription, prognostic markers and mediators. Eur Respir J 2007; 30: 556-73.
16. Linscheid P, Seboek D, Zulewski H, Keller U, Muller B. Autocrine/paracrine role of infl ammation-mediated calci-tonin gene-related peptide and adrenomedullin expression in human adipose tissue. Endocrinology 2005; 146: 2699-708.
17. Schuetz P, Christ-Crain M, Muller B. Procalcitonin and other biomarkers to improve assessment and antibiotic stewardship in infections-hope for hype? Swiss Med Wkly 2009; 139: 318-26.
18. Richter SS, Beekmann SE, Croco JL, Diekema DJ, Koontz FP, Pfaller MA, et al. Minimizing the workup of blood culture contaminants: implementation and evaluation of a laboratory-based algorithm. J Clin Microbiol 2002; 40: 2437-44.
19. Dellinger RP, Levy MM, Rhodes A, Annane D, Gerlach H, Opal SM, et al. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012. Crit Care Med 2013; 41: 580-637.
20. Assicot M, Gendrel D, Carsin H, Raymond J, Guilbaud J, Bohuon C. High serum procalcitonin concentrations in patients with sepsis and infection. Lancet 1993; 341: 515-18.
21. Muller F, Christ-Crain M, Bregenzer T, Krause M, Zimmerli W, Mueller B, et al. Procalcitonin levels predict bacteremia in patients with community-acquired pneumonia: a prospective cohort trial. Chest 2010; 138: 121-9.
22. van Nieuwkoop C, Bonten TN, Van'T WJ, Kuijper EJ, Groe-neveld GH, Becker MJ, et al. Procalcitonin refl ects bactere-mia and bacterial load in urosepsis syndrome: a prospective observational study. Crit Care 2010; 14: R206.
23. Kasem AJ, Bulloch B, Henry M, Shah K, Dalton H. Procal-citonin as a marker of bacteremia in children with fever and a central venous catheter presenting to the emergency department. Pediatr Emerg Care 2012; 28: 1017-21.
24. Chirouze C, Schuhmacher H, Rabaud C, Gil H, Khayat N, Estavoyer JM, et al. Low serum procalcitonin level accurately predicts the absence of bacteremia in adult patients with acute fever. Clin Infect Dis 2002; 35: 156-61.
25. Liaudat S, Dayer E, Praz G, Bille J, Troillet N. Usefulness of procalcitonin serum level for the diagnosis of bacteremia. Eur J Clin Microbiol Infect Dis 2001; 20: 524-7.
26. Naffaa M, Makhoul BF, Tobia A, Kaplan M, Aronson D, Azzam ZS, et al. Procalcitonin and interleukin 6 for predicting blood culture positivity in sepsis. Am J Emerg Med 2014; 32: 448-51.
27. Choi SH, Choi SH. Predictive performance of serum procalcitonin for the diagnosis of bacterial meningitis after neurosurgery. Infect Chemother 2013; 45: 308-14.
28. Schwarz S, Bertram M, Schwab S, Andrassy K, Hacke W. Serum procalcitonin levels in bacterial and abacterial meningitis. Crit Care Med 2000; 28: 1828-32.
29. van Rossum AM, Wulkan RW, Oudesluys-Murphy AM. Procalcitonin as an early marker of infection in neonates and children. Lancet Infect Dis 2004; 4: 620-30.
30. Simon L, Gauvin F, Amre DK, Saint-Louis P, Lacroix J. Serum procalcitonin and C-reactive protein levels as markers of bacterial infection: a systematic review and meta-analysis. Clin Infect Dis 2004; 39: 206-17.
31. Jereb M, Muzlovic I, Hojker S, Strle F. Predictive value of serum and cerebrospinal fl uid procalcitonin levels for the diagnosis of bacterial meningitis. Infection 2001; 29: 209-12.
32. Tian G, Pan SY, Ma G, Liao W, Su QG, Gu BC, et al. Serum levels of procalcitonin as a biomarker for differentiating between sepsis and systemic infl ammatory response syndrome in the neurological intensive care unit. J Clin Neurosci 2014; 21: 1153-8.
33. Hedegaard SS, Wisborg K, Hvas AM. Diagnostic utility of biomarkers for neonatal sepsis-a systematic review. Infect Dis (Lond) 2015; 47: 117-24.
34. Wacker C, Prkno A, Brunkhorst FM, Schlattmann P. Procalcitonin as a diagnostic marker for sepsis: a systematic review and meta-analysis. Lancet Infect Dis 2013; 13: 426-35.
35. Kim H, Kim Y, Lee HK, Kim KH, Yeo CD. Comparison of the delta neutrophil index with procalcitonin and C-reactive protein in sepsis. Clin Lab 2014; 60: 2015-21.
36. de Azevedo JR, Torres OJ, Beraldi RA, Ribas CA, Malafaia O. Prognostic evaluation of severe sepsis and septic shock: procalcitonin clearance vs Sequential Organ Failure Assessment. J Crit Care 2015; 30: 219.e9-12.
37. Meng FS, Su L, Tang YQ, Wen Q, Liu YS, Liu ZF. Serum procalcitonin at the time of admission to the ICU as a predictor of short-term mortality. Clin Biochem 2009; 42: 1025-31.
38. Karlsson S, Heikkinen M, Pettila V, Alila S, Vaisanen S, Pulkki K, et al. Predictive value of procalcitonin decrease in patients with severe sepsis: a prospective observational study. Crit Care 2010; 14: R205.
39. Schuetz P, Maurer P, Punjabi V, Desai A, Amin DN, Gluck E. Procalcitonin decrease over 72 hours in US critical care units predicts fatal outcome in sepsis patients. Crit Care 2013; 17: R115.
40. Lee CC, Chen SY, Tsai CL, Wu SC, Chiang WC, Wang JL, et al. Prognostic value of mortality in emergency department sepsis score, procalcitonin, and C-reactive protein in patients with sepsis at the emergency department. Shock 2008; 29: 322-7.